Medical Marijuana (MMJ)

Our top cannabis news topics this week: Texas medical cannabis, first Native American-owned East Coast cannabis brand, pivoting with hemp manufacturing, low-dose CBD and stress, and alcohol-induced liver disease.

The Texas Department of Public Safety has announced a list of nine businesses that will move forward in Phase I of the Texas Compassionate Use Program.

A study looked into the beneficial role THC-CBD cannabis extracts may play with Alzheimer’s disease-associated dementia.

A new study finds that THC:CBD cannabis oil may improve appetite and quality of life in systemic sclerosis patients.

The new study found that education intervention resulted in improvements in patient symptom management.

Dr. Dustin Sulak reviews studies on medical cannabis in this month’s webinar, including research on Tourette syndrome, chemotherapy-induced neuropathy, and caregiver wellbeing.

According to a recent study, plant-derived cannabis extracts containing THC, CBD, and CBG, may offer superior short-term and long-term pain relief than opioids for chronic lower back pain patients.

What role does cannabis play in sleep quality and health-related conditions?

Our top five cannabis and hemp news this week: cannabis sales milestones in Minnesota and Virginia, new CBD research, and Colorado’s latest regulatory updates.

The Virginia Cannabis Control Authority reported data on medical cannabis sales and most popular products for July to August 2025.

A UK Medical Cannabis Registry study found cannabis-based medicines improved sleep, anxiety, and quality of life in insomnia patients.

According to the Division of Cannabis Control, medical marijuana sales exceeded $2.2 billion and recreational cannabis generated over $785 million since legalization.

The FY26 CJS Appropriations Act includes Section 607, barring cannabis rescheduling. Advocates warn the Act threatens medical cannabis protections.

The exploratory analysis suggest that lower costs and reliable supply could affect reliance on illegal medical cannabis in Utah.

In the second part of this webinar coverage, Dustin Sulak, DO, explains recent research and studies on cannabinoids and their effect on sleep and conditions affecting sleep.

In this month’s webinar, Dustin Sulak, DO, explains recent research and studies on cannabinoids and their effect on sleep and conditions affecting sleep.

A scoping review of 41 studies finds physicians nationwide report a lack sufficient training to counsel patients on medical cannabis use, with mixed perceptions on favorability of its use.

Here, we bring you our top five recent articles covering revoking medical cannabis cards in Florida, testing and sampling initiative in Missouri, our mid-year regulations roundup, depenalization ordinance stopped in Texas, and accuracy in THC labeling in flower versus concentrates.

Here, we bring you our top five recent articles covering medical cannabis in Texas, cease-and-desist letter response, pardons in Maryland, cannabis in Thailand, and research on autism and cannabis.

The newly published regulations classify cannabis flowers as controlled herbs, requiring prescriptions and licensed handling.

Here, we bring you our top five recent articles covering medical cannabis in Hawaii, a new dispensary in Connecticut, pesticide testing in California, a cease-and-desist letter to a dispensary on Long Island, and a global survey on cannabis for endometriosis.

A survey of nearly 900 endometriosis patients across 28 countries highlights cannabis as a preferred alternative to pharmaceuticals, despite legal, social, and medical communication barriers.

According to two House Bills, medical cannabis must now be sold in pre-packaged form, with new regulations and licenses for transportation, storage, and security of facilities.

In this month’s webinar, Dustin Sulak, DO, summarizes and provides insights on cannabis studies for chronic pain, restless leg syndrome, insomnia, effects on driving, and more.

As Texas advances legislation to ban hemp-derived THC, HB 46 seeks to expand the state’s medical cannabis program, with several recent changes.